Trial reportDiabetologia2026
The glycaemic response to morning fasted resistance exercise is more consistent than the response to afternoon fed resistance exercise for adults with type 1 diabetes: a randomised crossover comparison.
Trial report in Diabetologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05168488 (Repeatability of Blood Glucose Responses to Fasted and Fed Resistance Exercise in Individuals With Type 1 Diabetes), which is not on this map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Repeatability of Blood Glucose Responses to Fasted and Fed Resistance Exercise in Individuals With Type 1 Diabetes
Who cites it
4 citing papers in PubMed.
- A Comparison of the Effects of the Timing of Resistance Exercise on Glucose Levels Within the Target Range in People With Type 1 Diabetes (TREX Study): A Randomized Crossover Trial.Diabetes/metabolism research and reviews · 2026Trial
- Exercise timing or feeding status? Interpreting glycaemic responses to resistance exercise in type 1 diabetes. Reply to Gray S, Al-Awadhi A, Al-Ozairi E [letter].Diabetologia · 2026Article
- Exercise timing or feeding status? Interpreting glycaemic responses to resistance exercise in type 1 diabetes.Diabetologia · 2026Article
- Artificial intelligence-driven therapeutics for disease modification in type 1 diabetes: a digital public health and clinical translation framework.Frontiers in public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
aims/hypothesisPeople with type 1 diabetes are recommended to modify insulin dosing and/or carbohydrate intake before, during and after exercise to manage blood glucose levels and prevent hypoglycaemia. An exercise strategy that produces a more consistent glycaemic response may facilitate glycaemic management around exercise, thereby reducing barriers to exercise related to blood glucose concentration, such as fear of hypoglycaemia, for people with type 1 diabetes. The aim of this study was to compare the consistency of the glycaemic response to resistance exercise performed in the morning while fasted vs in the afternoon after eating.
methodsTwelve adults with type 1 diabetes, HbA
resultsThe wpSD of the change in capillary glucose during exercise was lower for AM-FAST (1.0±1.1 mmol/l) than PM-FED (1.5±1.0 mmol/l; p=0.029). There was no difference in the wpSD between conditions during the subsequent 30 min seated recovery (p=0.76). During exercise capillary glucose increased by 1.4±1.9 mmol/l for AM-FAST and decreased by 0.9±2.3 mmol/l for PM-FED (p=0.017). There was a greater percentage of time in hyperglycaemia in the 6 h post-exercise period following AM-FAST vs PM-FED (56.7% [27.2, 67.9] vs 33.0% [22.6, 41.5]; p=0.003, respectively). CONCLUSIONS/
interpretationThe glycaemic response to AM-FAST was more consistent and characterised by increases in glucose concentration, whereas the glycaemic response to PM-FED was less consistent and produced decreases in glucose concentration. Performing resistance exercise while fasted may reduce barriers to exercise for people with type 1 diabetes due to a more consistent glycaemic response that is less likely to cause hypoglycaemia during exercise.
trial registrationClinicalTrials.gov NCT05168488.
fundingDexcom Canada provided in-kind funding in the form of Dexcom G6 transmitters, sensors and receivers. LifeScan Canada provided in-kind funding in capillary glucose testing strips. JEY was supported by a Heart and Stroke Foundation of Canada Alberta New Investigator Award.
Indexed as
Identifiers
41831023What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.